CELL DEATH AND DIFFERENTIATION
Scope & Guideline
Bridging Knowledge Gaps in Cell Biology and Molecular Mechanisms
Introduction
Aims and Scopes
- Cell Death Mechanisms:
The journal explores the molecular pathways and mechanisms that regulate various forms of cell death, including programmed cell death (apoptosis), necroptosis, and autophagy, shedding light on their roles in health and disease. - Differentiation and Development:
Research articles focus on the processes of cell differentiation, including stem cell biology and developmental mechanisms, providing insights into how cells acquire specific functions and identities. - Cancer Biology:
The journal includes studies that investigate the relationship between cell death and cancer, exploring how tumor cells evade death, the role of cell death in tumor progression, and the potential for therapeutic targeting of cell death pathways. - Immunology and Inflammation:
Research on the interplay between cell death mechanisms and immune responses, particularly how cell death influences inflammation and immune regulation, is a core focus area. - Regenerative Medicine:
The journal emphasizes the implications of cell death and differentiation in regenerative medicine, including studies that explore therapeutic strategies to promote tissue regeneration and repair. - Metabolism and Cell Fate:
The interactions between metabolic processes and cell death are examined, highlighting how metabolic stress can influence cell survival and differentiation.
Trending and Emerging
- Ferroptosis Research:
Ferroptosis has emerged as a significant area of study, with increasing research focused on its role in cancer, neurodegeneration, and metabolic diseases. This interest is driven by the recognition of ferroptosis as a distinct form of regulated cell death that has therapeutic potential. - Interplay Between Metabolism and Cell Death:
There is a growing emphasis on understanding how cellular metabolism influences cell fate decisions, particularly in the context of cancer and metabolic disorders. This includes research on metabolic reprogramming and its effects on cell survival and death. - Cell Death in Immune Responses:
Research exploring the role of cell death mechanisms in modulating immune responses and inflammation is gaining traction, particularly in the context of autoimmune diseases and cancer immunotherapy. - Stem Cell Differentiation and Plasticity:
The study of stem cell differentiation processes and their regulation has become increasingly important, particularly regarding how cell death influences stem cell fate and tissue homeostasis. - Epigenetic Regulation of Cell Death:
Emerging research is focusing on the epigenetic modifications that regulate cell death pathways, highlighting the role of chromatin dynamics in controlling cell fate decisions. - Therapeutic Targeting of Cell Death Pathways:
There is a notable trend towards developing therapeutic strategies that target cell death pathways in cancer treatment, with an emphasis on exploiting vulnerabilities in tumor cells to induce cell death.
Declining or Waning
- Traditional Apoptosis Research:
Research focusing solely on classical apoptosis mechanisms has seen a decline as newer forms of cell death, such as ferroptosis and necroptosis, gain prominence. The field is moving towards more integrative approaches that encompass multiple cell death modalities. - Basic Mechanistic Studies:
There appears to be a waning interest in purely mechanistic studies of cell death pathways without a clear connection to disease models or therapeutic implications, as researchers increasingly seek to link findings to clinical relevance. - Single-Cell Analyses:
Although single-cell approaches have gained traction, traditional bulk analysis methods are being overshadowed by the demand for more nuanced, heterogeneity-focused studies that address cellular responses at a single-cell level. - In Vivo Models of Cell Death:
Research using simplistic in vivo models to study cell death mechanisms is declining in favor of more complex, human-relevant models that better mimic disease conditions, particularly in cancer and regenerative contexts.
Similar Journals
Cells
Illuminating the World of Cells Through Groundbreaking ResearchCells, published by MDPI in Switzerland, is a leading open-access journal that has been disseminating groundbreaking research in the fields of Biochemistry, Genetics, and Molecular Biology since its inception in 2011. With an impressive E-ISSN of 2073-4409, the journal boasts a strong impact factor and ranks in the 84th percentile for Scopus ratings, underscoring its significance in advancing scientific knowledge. As a Q1-ranked journal in both 2023 and 2020, it serves as a premier platform for researchers, professionals, and students eager to explore innovative findings and methodologies. By providing unrestricted access to high-quality research, Cells plays a pivotal role in facilitating collaboration and inspiration within the global scientific community, making it an indispensable resource for anyone interested in cutting-edge discoveries in cellular biology.
Cell Death Discovery
Fostering innovation in the study of cell death.Cell Death Discovery, published by Springer Nature, is a distinguished open-access journal dedicated to advancing the field of cell death research. Since its inception in 2015, the journal has rapidly established itself as a premier platform for high-quality research, currently holding a remarkable position in the Q1 quartiles across multiple categories, including Cancer Research, Cell Biology, Cellular and Molecular Neuroscience, and Immunology. With an impact factor reflecting its significant contribution to the scientific community, Cell Death Discovery invites submissions that explore the molecular mechanisms of cell death and its implications across various biomedical fields. The journal's open-access model ensures that groundbreaking research is accessible to a global audience, facilitating collaboration and dissemination among researchers, professionals, and students alike. Located in the UK, at CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND, the journal continues to support innovative scholarship and foster a deeper understanding of the processes behind cell viability, development, and disease.
ACTA HISTOCHEMICA
Transforming Histochemical Discoveries into Medical AdvancementsACTA HISTOCHEMICA, a prestigious journal published by Elsevier GmbH, is dedicated to advancing the field of histochemistry and its applications within cell biology and medicine. With an ISSN of 0065-1281 and an E-ISSN of 1618-0372, the journal provides a critical platform for the dissemination of high-quality research findings and reviews, integral for both emerging and established scholars. Since its inception in 1954 and continuing through to 2024, ACTA HISTOCHEMICA has maintained a strong commitment to publishing significant advancements in histology and cell biology, as evidenced by its categorization in Q3 for Cell Biology and Histology, as well as Q2 in miscellaneous medicine for the year 2023. The journal ranks favorably in Scopus, holding the 27th rank in Histology and a 200th rank in Cell Biology, highlighting its importance to the academic community. With its headquarters in Munich, Germany, ACTA HISTOCHEMICA continues to attract contributions from global researchers, fostering an international dialogue essential for the growth of knowledge in histochemistry and related disciplines.
NATURE REVIEWS MOLECULAR CELL BIOLOGY
Pioneering knowledge synthesis in molecular and cellular biology.NATURE REVIEWS MOLECULAR CELL BIOLOGY, published by NATURE PORTFOLIO, stands as a seminal journal in the fields of cell and molecular biology, with a significant impact factor that underscores its influence and reputation within the scientific community. Established in 2000 and continuing its legacy into 2024, this journal delivers comprehensive reviews that synthesize current knowledge and advancements in molecular and cellular processes. Respected for its high-quality articles, it has maintained a prestigious Q1 ranking in both Cell Biology and Molecular Biology categories as of 2023. With an exceptional Scopus ranking, taking the top position in its category, it attracts a readership of prominent researchers, professionals, and students eager to stay abreast of groundbreaking discoveries and methodologies. Although it does not offer Open Access, subscribers benefit from exclusive access to vital insights that foster innovative research approaches and advancements in the life sciences. The journal’s objective is to bridge the gap between research and application, providing indispensable resources to its audience while contributing to the global conversation on molecular and cellular biology.
Cell Division
Illuminating the pathways of cellular processes.Cell Division, an esteemed journal published by BMC, serves as a critical platform for researchers in the fields of biochemistry, cell biology, and molecular biology, showcasing groundbreaking studies and novel insights in the mechanisms governing cell division. Since its establishment in 2006, this Open Access journal, based in the United Kingdom, has strived to promote rigorous scientific discourse, ensuring unrestricted access to its rich content. With a commendable impact factor reflected in its Q1 and Q2 categorizations across various biological disciplines, Cell Division is recognized for its influence and relevance in the academic community. Targeting professionals, researchers, and students alike, it aims to disseminate high-quality research findings that further our understanding of cellular processes and contribute to advances in medical and biotechnological applications. Engage with leading-edge research and broaden your knowledge base in cell biology through this dynamic publication that continues to evolve through 2024 and beyond.
BIOCELL
Connecting Researchers for a Deeper Understanding of Life SciencesBIOCELL is a distinguished peer-reviewed journal dedicated to the field of Cell Biology, published by TECH SCIENCE PRESS. Since its inception in 1995, the journal has been at the forefront of disseminating innovative research, with converged publication years extending from 1995 to 2013 and from 2015 to 2024. Although it currently holds a Q4 ranking in the Cell Biology category according to the 2023 category quartiles, BIOCELL aims to foster advancements by providing a platform for researchers, professionals, and students to share their findings in biochemistry, genetics, and molecular biology. The journal is available in both print (ISSN: 0327-9545) and digital formats (E-ISSN: 1667-5746) and seeks to attract contributions that enhance scholarly dialogue and understandings of cellular mechanisms and innovations. With a commitment to quality research and critical discourse, BIOCELL plays an important role in nurturing the scientific community within Argentina and beyond, offering vital insights that contribute to the advancement of the life sciences.
CYTOTECHNOLOGY
Empowering Researchers: Unleashing Potential in Biomedical Innovation.CYTOTECHNOLOGY, an esteemed journal published by Springer, stands as a vital resource in the fields of Bioengineering, Biomedical Engineering, and Biotechnology. With an impact factor reflective of its solid position within academia, this journal encompasses a broad scope dedicated to the advancement of cytotechnological research and applications from its inception in 1987 through to its latest volumes in 2024. Based in the Netherlands, it is committed to providing researchers, professionals, and students with high-quality, peer-reviewed articles that contribute to the understanding and innovations in cytotechnology. Although currently not open access, CYTOTECHNOLOGY has garnered a commendable reputation, holding Q3 rankings in multiple categories, indicating its relevance and influence within the scientific community. Researchers are encouraged to submit their cutting-edge findings to share insights that can spark further advancements in this dynamic field.
DIFFERENTIATION
Illuminating the Pathways of Molecular ProcessesDIFFERENTIATION is a respected peer-reviewed journal published by Elsevier Science Ltd, dedicated to advancing knowledge in the fields of Cancer Research, Cell Biology, Developmental Biology, and Molecular Biology. With an established history since 1973, the journal continuously explores the intricacies of cellular and molecular processes that govern differentiation in biological systems, thus playing a pivotal role in shaping contemporary research directions. Currently indexed in the Q3 quartile across multiple relevant categories, it provides a crucial platform for researchers to disseminate their findings and engage with the scientific community. DIFFERENTIATION does not offer open access, but it remains a valuable resource for academics seeking to enhance their understanding of the fundamental mechanisms that underpin life sciences. By fostering a rigorous dialogue among scientists, it contributes significantly to the ever-evolving landscape of biochemistry and genetics.
DEVELOPMENTAL CELL
Transforming Insights into Cellular ProcessesDEVELOPMENTAL CELL, published by CELL PRESS, stands as a premier journal in the fields of Biochemistry, Genetics and Molecular Biology, Cell Biology, and Developmental Biology. With a significant influence evidenced by its Q1 rankings across several categories in 2023 and a remarkable Scopus ranking placing it at the 98th percentile for Developmental Biology, this journal is pivotal for researchers and academics aiming to advance their understanding of cellular processes. Covering a broad range of topics from molecular mechanisms to cellular developmental pathways, DEVELOPMENTAL CELL publishes cutting-edge research articles that contribute to the dynamic landscape of cell biology and related disciplines. Although it does not currently offer open access, the journal is accessible through institutional subscriptions, reinforcing its commitment to disseminating high-quality scientific knowledge produced by leading experts in the field. Based in the United States, DEVELOPMENTAL CELL continues to push the boundaries of discovery and innovation in life sciences, making it an essential resource for professionals, researchers, and students alike in the quest for foundational biological insights.
Cell Stem Cell
Leading the Charge in Cellular Genetics and Molecular MedicineCell Stem Cell, published by CELL PRESS, is a premier journal at the forefront of cellular biology, genetics, and molecular medicine. With an esteemed impact factor and recognized as a Q1 journal in multiple categories including Cell Biology, Genetics, and Molecular Medicine, it offers researchers, professionals, and students rigorous, peer-reviewed articles that shape the future of stem cell research and regenerative medicine. Located in Cambridge, MA, this journal has become an invaluable resource since its inception in 2007 and is committed to disseminating groundbreaking findings that drive innovation and understanding in these critical fields. By consistently ranking within the top percentile of its categories in Scopus, Cell Stem Cell remains an essential platform for scholarly communication, fostering collaboration among leading scientists worldwide. Although the journal does not currently offer open access options, its comprehensive insights are pivotal for anyone engaged in the study of stem cells and their applications.